On ECHEMI
Home > Drugs > Beijing Sciecure Pharmaceutical Co., Ltd.
Beijing Sciecure Pharmaceutical Co., Ltd.
  • Founded in:

    2002-04-10
  • Country:

    China China
  • Address:

    Zhongbei Industrial Zone, Beishicao Town, Shunyi District, Beijing
  • Tax NO.:

    91110113737672872E
  • Registered Funds:

    88.49 million yuan
  • Website:

  • Email:

Related Drugs
Metahydroxylamine bitartrate injection
(-)-α(1-aminoethyl)-3-hydroxybenzyl alcohol bitartrate
Name Description Content CAS NO. Registered Holders
(-)-α(1-aminoethyl)-3-hydroxybenzyl alcohol bitartrate

This product mainly acts on α receptors, directly stimulating α receptors. Its effect is weaker than that of norepinephrine but more persistent. Its cardiovascular effect is similar to that of norepinephrine. It can constrict blood vessels, continuously increase systolic and diastolic blood pressure, and enhance myocardial contractility. The cardiac output of normal people does not change much, but it can increase the cardiac output of patients with shock. The excitement of heart rate is not very significant, rarely causes arrhythmia, and has no central nervous system excitation effect. Because its pressor effect is reliable and lasts for a long time, it rarely causes reactions such as palpitations or decreased urine volume. When administered continuously, because this product indirectly replaces the transmitter in the adrenergic nerve vesicles, it can reduce the transmitter and weaken the intrinsic effect. Therefore, it cannot be stopped suddenly to avoid rebound hypotension.

More

This product mainly acts on α receptors, directly stimulating α receptors. Its effect is weaker than that of norepinephrine but more persistent. Its cardiovascular effect is similar to that of norepinephrine. It can constrict blood vessels, continuously increase systolic and diastolic blood pressure, and enhance myocardial contractility. The cardiac output of normal people does not change much, but it can increase the cardiac output of patients with shock. The excitement of heart rate is not very significant, rarely causes arrhythmia, and has no central nervous system excitation effect. Because its pressor effect is reliable and lasts for a long time, it rarely causes reactions such as palpitations or decreased urine volume. When administered continuously, because this product indirectly replaces the transmitter in the adrenergic nerve vesicles, it can reduce the transmitter and weaken the intrinsic effect. Therefore, it cannot be stopped suddenly to avoid rebound hypotension.

0
Sodium Nitroprusside
Name Description Content CAS NO. Registered Holders
Sodium nitroprusside dihydrate

Extract from the above information

More

Extract from the above information

13755-38-9 29
Salmon calcitonin
Name Description Content CAS NO. Registered Holders
Calcitonin salmon

Extract from the above information

More

Extract from the above information

47931-85-1 16
nicotine
Name Description Content CAS NO. Registered Holders
Nicotine

0
Thymopentin injection
N-[N-[N-(Nα-L-arginyl-L-lysyl)-L-α-aspartyl]-L-valyl]-L-tyrosine
Name Description Content CAS NO. Registered Holders
N-[N-[N-(Nα-L-arginyl-L-lysyl)-L-α-aspartyl]-L-valyl]-L-tyrosine

This product is an immunomodulatory drug. It has the function of regulating and enhancing the cellular immune function of the human body. It can promote the maturation of T lymphocytes in the peripheral blood after mitogen activation, increase the secretion of various lymphokines (such as alpha, gamma interferon, interleukin 2 and interleukin 3) after T cells are activated by various antigens or mitogens, and increase the level of lymphokine receptors on T cells. It also enhances the response of lymphocytes by activating T4 helper cells. In addition, this product may affect the chemotaxis of NK precursor cells, which become more cytotoxic after exposure to interferon. Therefore, this product has the function of regulating and enhancing the cellular immune function of the human body. This product is an immune bidirectional modulatory drug. It has the function of inducing and promoting the differentiation, maturation and activation of T lymphocytes and their subsets, regulating T lymphocytes.

More

This product is an immunomodulatory drug. It has the function of regulating and enhancing the cellular immune function of the human body. It can promote the maturation of T lymphocytes in the peripheral blood after mitogen activation, increase the secretion of various lymphokines (such as alpha, gamma interferon, interleukin 2 and interleukin 3) after T cells are activated by various antigens or mitogens, and increase the level of lymphokine receptors on T cells. It also enhances the response of lymphocytes by activating T4 helper cells. In addition, this product may affect the chemotaxis of NK precursor cells, which become more cytotoxic after exposure to interferon. Therefore, this product has the function of regulating and enhancing the cellular immune function of the human body. This product is an immune bidirectional modulatory drug. It has the function of inducing and promoting the differentiation, maturation and activation of T lymphocytes and their subsets, regulating T lymphocytes.

0
  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.